MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $686,015 | -40.1% | 42,769 | -13.4% | 0.00% | 0.0% |
Q2 2023 | $1,145,393 | +57.6% | 49,413 | +53.2% | 0.00% | 0.0% |
Q1 2023 | $726,615 | +76.0% | 32,251 | +13.4% | 0.00% | – |
Q4 2022 | $412,766 | -12.0% | 28,447 | +15.6% | 0.00% | – |
Q3 2022 | $469,000 | +10.1% | 24,599 | +4.9% | 0.00% | – |
Q2 2022 | $426,000 | +1.9% | 23,448 | +41.2% | 0.00% | – |
Q1 2022 | $418,000 | +11.5% | 16,607 | +22.3% | 0.00% | – |
Q4 2021 | $375,000 | +1.6% | 13,580 | +18.8% | 0.00% | – |
Q3 2021 | $369,000 | -64.4% | 11,435 | -66.3% | 0.00% | -100.0% |
Q2 2021 | $1,037,000 | +13.6% | 33,908 | +13.1% | 0.00% | 0.0% |
Q1 2021 | $913,000 | -39.8% | 29,970 | -46.2% | 0.00% | 0.0% |
Q4 2019 | $1,517,000 | -62.3% | 55,701 | -60.3% | 0.00% | -75.0% |
Q3 2019 | $4,019,000 | +0.6% | 140,369 | -2.4% | 0.00% | 0.0% |
Q2 2019 | $3,994,000 | -2.4% | 143,755 | +16.7% | 0.00% | 0.0% |
Q1 2019 | $4,091,000 | +45.8% | 123,221 | +27.7% | 0.00% | +33.3% |
Q4 2018 | $2,805,000 | -28.4% | 96,492 | +13.4% | 0.00% | -25.0% |
Q3 2018 | $3,916,000 | +162.5% | 85,120 | +68.6% | 0.00% | +100.0% |
Q1 2018 | $1,492,000 | -12.4% | 50,486 | +1.8% | 0.00% | 0.0% |
Q4 2017 | $1,703,000 | -58.9% | 49,586 | -56.7% | 0.00% | -50.0% |
Q3 2017 | $4,140,000 | -7.5% | 114,416 | -34.0% | 0.00% | -20.0% |
Q2 2017 | $4,477,000 | +31.1% | 173,266 | -2.6% | 0.01% | +25.0% |
Q1 2017 | $3,414,000 | +46.8% | 177,835 | +27.5% | 0.00% | +33.3% |
Q4 2016 | $2,325,000 | -67.7% | 139,498 | -60.1% | 0.00% | -62.5% |
Q3 2016 | $7,200,000 | -21.8% | 349,846 | +16.3% | 0.01% | -20.0% |
Q2 2016 | $9,207,000 | -2.1% | 300,884 | +19.7% | 0.01% | -9.1% |
Q1 2016 | $9,406,000 | +17.5% | 251,301 | +35.5% | 0.01% | +22.2% |
Q4 2015 | $8,003,000 | +3657.3% | 185,429 | +3158.9% | 0.01% | – |
Q3 2015 | $213,000 | -89.5% | 5,690 | -89.2% | 0.00% | -100.0% |
Q3 2014 | $2,036,000 | -0.4% | 52,778 | +0.4% | 0.00% | 0.0% |
Q2 2014 | $2,045,000 | -72.8% | 52,545 | -76.1% | 0.00% | -77.8% |
Q1 2014 | $7,508,000 | -51.3% | 219,586 | -70.1% | 0.01% | -50.0% |
Q4 2013 | $15,402,000 | +48.0% | 734,116 | +65.8% | 0.02% | +38.5% |
Q3 2013 | $10,406,000 | +2508.0% | 442,822 | +2883.2% | 0.01% | +1200.0% |
Q2 2013 | $399,000 | – | 14,844 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |